Search results
Results from the WOW.Com Content Network
Patients who are medically stable and who have low viral load for two years may get viral load counts every 6 months instead of 3. [1] If a viral load count is not stable or sufficiently low, then that might be a reason to modify the HIV treatment. [1] If HIV treatment is changed, then the viral load should be tested 2–8 weeks later. [1]
The International Journal of STD & AIDS is a monthly peer-reviewed medical journal that covers the field of immunology as applied to sexually-transmitted diseases and HIV/AIDS. Its editor-in-chief is John White (Guy's and St Thomas' NHS Foundation Trust). It was established in 1990 and is published by SAGE Publications.
AIDS is a peer-reviewed scientific journal that is published by Lippincott Williams & Wilkins. It was established in 1987 and is an official journal of the International AIDS Society . [ 1 ] It covers all aspects of HIV and AIDS , including basic science, clinical trials , epidemiology , and social science .
In the United Kingdom the BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018 [7] recommend: . On-demand or daily oral Tenofovir – emtricitabine (TD-FTC) for HIV-negative MSM who are at elevated risk of HIV acquisition through unprotected anal sex in the previous six months and ongoing unprotected anal sex.
AIDS and Behavior is a peer-reviewed medical journal covering behavioral aspects of HIV/AIDS research. It was established in 1997 and is published nine times per year by Springer Science+Business Media. The editor-in-chief is Seth Kalichman (University of Connecticut).
Kaposi's Sarcoma (KS) is an extremely common disease that arises in AIDS patients and HIV-infected individuals. The condition is characterized by large purple lesions on the skin and mouth. KS presents itself differently for everyone affected by it, and its symptoms and progression varies from person to person as well. [ 5 ]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
The HIV-1 virus has proved to be tenacious, inserting its genome permanently into patients' DNA, forcing patients to take a lifelong drug regimen to control the virus and prevent a fresh attack. Now, a team of Temple University School of Medicine researchers have designed a way to "snip out" the integrated HIV-1 genes for good.